Search:

Login | Subscribe

Home > Companies > Hutchison China Meditech

Price	Market	Sector	Market Cap
63.50p (-3.00p) -4.51%	AIM	Medicine and Biotech Research	£32.52m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
CBF	2.00p	-11.11%
CRX	2.75p	0.00%
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	28.25p	-2.59%
GMX	1.75p	0.00%
GWP	30.00p	0.00%
HML	0.42p	0.00%
MMG	7.25p	0.00%
MPM	14.25p	0.00%
OMH	3.50p	0.00%
PLE	16.50p	0.00%
PRM	20.50p	-8.89%
PRX	145.00p	5.46%
RNSM	7.75p	0.00%
RCG	35.00p	-6.67%
RGT	6.50p	0.00%

Commentary

Pharmaceutical and healthcare group primarily based in China

Recent Articles

Chi-Med bullish despite interim losses	06/08/2008
Hutchison China MediTech	16/08/2006
The week ahead, floats and results	09/08/2006
Newcomer - Hutchison China Meditech	19/05/2006
Chinese medical group takes AIM	10/04/2006

Recent Announcements

Chi-Med Expands Partnership With Lilly	21/11/2008
Hutchison MediPharma Wins ACG Award	30/10/2008
Board Change	08/10/2008
Hutchison MediPharma Employee	06/08/2008
Interim Results	06/08/2008
Notice of Results	18/07/2008
Blocklisting Six Monthly Retu	30/06/2008
Director/PDMR Shareholding	10/06/2008
Directorate Change	02/06/2008
Chi-Med increases stake in Hu	23/05/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/12/2005	31/12/2006	31/12/2007
Currency	USD	USD	USD
Turnover	37.86	50.43	65.11
Operating Profit	-5.72	-5.38	-9.72
Pretax Profit	-6.23	-5.77	-10.02
Earnings After Tax	-6.37	-5.77	-10.86
Profit Available For Dividend	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00
Retained Profit	0.00	0.00	0.00
Shareholders Funds	-33.67	102.95	90.30
Net Current Assets	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00
Adj Earnings Per Share	0.00	0.00	0.00
Dividend Per Share	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	21st Floor, Hutchison House, 10 Harcourt Road, Hong Kong
Telephone	+852 2121 8200
Fax	+852 2121 8281
Executives
Executive Chairman	Simon To (0.00% holding)
Chief Executive	Christian Hogg (1.10% holding)
Finance Director	(0.00% holding)
Senior Independent Dir.	Christopher Nash (0.03% holding)
Main Shareholders
	Hutchison Healthcare Holdings: 71.6% Lansdowne Partners: 6.7% Cazenove Capital Management: 5.1%
Advisers
Nominated Adviser	Lazard
Nominated Broker	Investec Investment Banking
Solicitors	DLA Piper
Auditors	PricewaterhouseCoopers
Registrar	Computershare Investor Services

Commentary
Pharmaceutical and healthcare group primarily based in China
Company Data
Code	HCM
Sedol	KYG4672N10
Shares In Issue	51.212 m
Indices
Entry on AIM	19/05/2006
Interim Results	Aug
Final Results	Mar
Year End	Dec
Accounts Due	n/a
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief